NEW METHOD FOR SYNTHESIZING 2-FLUOROCYCLOPROPANE CARBOXYLIC ACID

    公开(公告)号:US20180370893A1

    公开(公告)日:2018-12-27

    申请号:US16061880

    申请日:2017-04-25

    Abstract: Disclosed is a new method for synthesizing 2-fluorocyclopropanecarboxylic acid comprising: 1) performing reaction of 1,1-dichloro-1-fluoroethane with thiophenol in the presence of an alkali, to produce a phenyl sulfide intermediate; 2) performing oxidation reaction of the phenyl sulfide intermediate with Oxone; 3) performing elimination reaction of the product of Step 2) in the presence of an alkali, to obtain 1-fluoro-1-benzenesulfonyl ethylene; 4) performing addition reaction of the 1-fluoro-benzenesulfonyl ethylene with ethyl diazoacetate in the presence of a catalyst, to obtain a cyclopropane intermediate; 5) performing elimination reaction of the cyclopropane intermediate in the presence of an alkali before acidification, to obtain 2-fluorocyclopropanecarboxylic acid. Herein, the synthetic route is short, used materials are bulk commodities, and raw materials are inexpensive and readily available. The process can be safely scaled up by replacing commonly used mCPBA reagents with Oxone. Further, reaction yield is improved, production cost is greatly reduced, and operation is simplified.

    FLUORINATED CYCLOPROPANE ANALOGS OF GLUTAMIC ACID
    2.
    发明申请
    FLUORINATED CYCLOPROPANE ANALOGS OF GLUTAMIC ACID 审中-公开
    葡萄糖的氟化环丙烷类似物

    公开(公告)号:US20120190648A1

    公开(公告)日:2012-07-26

    申请号:US13386162

    申请日:2010-07-23

    Abstract: The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a mixture in all proportions of stereoisomers thereof, in particular a mixture of enantiomers, such as a racemic mixture, wherein R represents a (C1-C6)alkyl or (C1-C6)alkenyl group, optionally substituted by one or more groups chosen among an halogen atom, ORa, SRb, NRcRd, PO(ORe)(ORf), CO2Rg, SO2Rh SO3R1, P0(0H)(CH(0H)Rk), CN, N3 and NH—C(═NH)NH2, with Ra, Rb, Rc and Rd, representing, independently of each other, an hydrogen atom, a (C1-C6)alkyl group or a —CO—(C1-C6)alkyl group, Re, Rf, Rg, Rh and R1 representing, independently of each other, an hydrogen atom or a (C1-C6)alkyl group, and Rk representing an aryl or heteroaryl group, said group being optionally substituted by one or more groups selected from an halogen atom and NO2, as well as to the use thereof and to a process for preparing such a compound, to a pharmaceutical composition containing it and to synthesis intermediates.

    Abstract translation: 本发明涉及式(I)化合物或其药学上可接受的盐,立体异构体或其所有比例的立体异构体的混合物,特别是对映异构体的混合物,例如外消旋混合物,其中R表示(C1- 任选被一个或多个选自卤素原子,OR a,SR b,NR c R d,PO(OR e)(OR f),CO 2 R g,SO 2 R h SO 3 R 1,O(OH)(CH 3)中的基团取代的C 1 -C 6烷基或(C 1 -C 6) (0H)R k),CN,N 3和NH-C(= NH)NH 2,其中R a,R b,R c和R d彼此独立地表示氢原子,(C 1 -C 6)烷基或 - CO-(C 1 -C 6)烷基,Re,R f,R g,Rh和R 1彼此独立地表示氢原子或(C 1 -C 6)烷基,R k表示芳基或杂芳基,所述基团 任选被一个或多个选自卤素原子和NO 2的基团取代,以及其用途和制备这种化合物的方法,含有它的药物组合物和 ynthesis中间体。

Patent Agency Ranking